High Tech Pharm Co Ltd
KOSDAQ:106190
Relative Value
The Relative Value of one High Tech Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 15 830 KRW, High Tech Pharm Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
High Tech Pharm Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
H
|
High Tech Pharm Co Ltd
KOSDAQ:106190
|
168.3B KRW | 2.3 | 15.9 | 9.2 | 13.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
930.7B USD | 14.3 | 45.1 | 30.4 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.6B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.9B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.7B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.2B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.1B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD | 2.5 | 16.9 | 7.1 | 8.8 |